Skip to content
back
back
back
back
back

Our financial data in facts & figures

OUR GROUP REVENUES

EBITDA (2022)
77.2 (18.7% of turnover)
EBIT (2022)
51.7 (12.5% of turnover)
NET RESULT (2022)
37.8 (9.2% of turnover)

Related Documents

OUR GROUP FIGURES BY FOCUS AREA (€ Millions, 2022)
Net revenue
412,1
€ Millions
153,9 € Millions
JOINT CARE
82,2 € Millions
EYE CARE
47,5 € Millions
SKIN CARE
34,3 € Millions
CORTICOSTEROIDS
5,1 € Millions
ACTIVE SUBSTANCES
89,0 € Millions
OTHER
OUR FIGURES BY PRODUCT CATEGORY (2022)
42
PRESCRIPTION DRUGS
39
MEDICAL DEVICES
5
VACCINES
14
OTHER
OUR GROUP FIGURES BY GEOGRAPHICAL AREA (€ Millions, 2022)
Net revenue
410,1
€ Millions
216,2 € Millions
ITALY
112,7 € Millions
EUROPE
58,4 € Millions
USA
15,8 € Millions
MENA
7,0 € Millions
RoW

OUR GROUP

GOVERNANCE
Find out more